NEW_CURA-LEAF_1170x120_OCT

Charles Lucarelli

Amneal to release Kenalog-40 generic

Amneal to release Kenalog-40 generic

BRIDGEWATER, N.J. — Amneal Biosciences is set to roll out triamcinolone acetonide injectable suspension 40 mg/ml, a steriod used to treat inflammation. Amneal said its triamcinolone acetonide product will be the only AP-rated generic equivalent injectable suspension available, with just the Kenalog-40 brand from Bristol-Myers Squibb currently on the market. “This important launch demonstrates the

Amneal forms biosciences unit

Amneal forms biosciences unit

BRIDGEWATER, N.J. — Amneal Pharmaceuticals LLC has formed Amneal Biosciences, a new business unit. Amneal said Tuesday that the new subsidiary will focus exclusively on the commercialization of high-barrier-to-entry generic drugs and specialty pharmaceuticals — such as injectables, oncologics and biosimilars — health care providers worldwide. “Having a dedicated company focused on the unique needs and